The Latest Cardiac and Vascular News
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and first patient cases with the latest advancement in ischemic stroke treatment – the novel Zoom 7X Catheter for aspiration thrombectomy procedures. The newest addition to the company’s comprehensive Zoom Stroke System, the Zoom 7X Catheter […]
Late-Breaking Data Presented at Society of NeuroInterventional Surgery Annual Meeting Demonstrate Excellent Reperfusion Results and Unparalleled Safety with the Zoom System for Ischemic Stroke CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced a late-breaking abstract with data from the Imperative Trial evaluating aspiration with the Zoom System in stroke patients with M2 […]
Pivotal trial evaluates safety and efficacy of the Symphony Thrombectomy System for the removal of blood clots from the lungs CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced the completion of patient enrollment in its SYMPHONY-PE Study (NCT06062329), a pivotal Investigational Device Exemption (IDE) trial evaluating the safety and efficacy of […]
CAMPBELL, Calif. – Imperative Care, Inc. today announced the Zoom Stroke System has been further expanded with the launch of the Zoom DuoPort technology, which allows physicians to use the novel Continuous Dual Aspiration Technique (CDAT) on two Zoom Aspiration Catheters simultaneously from a single vacuum source. CDAT empowers physicians with enhanced […]
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced the appointment of Todd Van Horn as Chief Financial Officer. “Imperative Care is deeply committed to bringing together a strong balance of leaders with complementary expertise and a shared passion for elevating patient care,” said Fred Khosravi, CEO of Imperative Care. “We are […]
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony™ 16F Catheter, the company’s latest innovation designed to elevate care for patients with venous thrombosis, a serious condition caused by a blood clot forming in the veins of […]
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s Zoom System, making it the first comprehensive stroke thrombectomy system to include large-bore .088” catheters indicated for both access and aspiration when used with a Zoom Catheter. This clearance […]
July 25, 2024 08:00 AM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced the initial close of an oversubscribed Series E financing. The financing was led by Ally Bridge […]
Late-Breaking Data Presented at SNIS Suggest Lower Rates of Rescue Therapy Than Prior Thrombectomy Trials; Rapid Reperfusion Time; High Rates of Reperfusion July 24, 2024 01:30 PM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that late-breaking data from the Imperative Trial were presented at the Society of […]
July 17, 2024 08:00 AM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom™ 6F Insert Catheters, the company’s latest innovation in elevating stroke care and the first insert catheters developed specifically for ischemic stroke procedures. The company […]
